How Electronic Data Capture Will Change Health Care and Pharmaceutical MarketingDecision ResourcesDecember 22, 2005 12 Pages - SKU: DECR1204213 |
| Today, many businesses routinely capture documents and data for both regulatory and business intelligence purposes. Health care in the clinical setting has resisted this industry-transforming technology for nearly 20 years, citing the lack of user-friendly interfaces for busy health care providers, the lack of workflow understanding on the part of vendors, the expense and complexity of implementation and maintenance solutions, and, simply, the lack of a transparent return on investment for providers. The tide is turning, however, and both health care providers and biopharmaceutical companies will likely be swept up in the coming change. In a world where health information can be captured, measured, shared, and compared, patient health outcomes information will become a paramount form of business intelligence. Capture and analysis of heretofore unavailable data will provide outcomes data that will allow constant postmarketing surveillance, not just by the pharmaceuticals but also by insurers, caregivers, and the public. Data capture will identify changing patient treatment populations, bringing new opportunities in R&D and in targeted marketing. Finally, health data capture will feed into the growing consumer-directed health care movement, resulting in greater patient advocacy and awareness. Drugmakers will need to adapt their behavior and strategies to this rapidly developing landscape Please note: the PDF e-mail from publisher version of this report is for a global site license. |
Related Markets
Manufacturing, Packaging & Detailing Reports
- Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
- Perspective: TAKE Solutions Gives Leading Pharma an Edge in Drug Serialization
- The World Market for Over The Counter (OTC) Drugs
- Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases' Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation
- Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion
